Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$12,024,740
-6.6%
353,877
+0.7%
3.45%
-4.5%
Q2 2021$12,868,305
-17.7%
351,497
+0.8%
3.61%
-22.9%
Q1 2021$15,632,121
-20.7%
348,620
+0.9%
4.68%
-47.1%
Q4 2020$19,711,693
+11.7%
345,395
+0.4%
8.84%
-7.8%
Q3 2020$17,648,534
-13.4%
344,026
+0.8%
9.59%
-20.1%
Q2 2020$20,384,466
+46.2%
341,334
+0.8%
12.00%
-21.7%
Q1 2020$13,945,020
+111.6%
338,718
+219.9%
15.33%
+166.6%
Q4 2019$6,589,162105,8675.75%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders